Invivyd, Inc. Files 8-K on Security Holder Vote Matters
Ticker: IVVD · Form: 8-K · Filed: May 20, 2025 · CIK: 1832038
| Field | Detail |
|---|---|
| Company | Invivyd, INC. (IVVD) |
| Form Type | 8-K |
| Filed Date | May 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: IVVD
TL;DR
Invivyd filed an 8-K for a shareholder vote. Details TBD.
AI Summary
Invivyd, Inc. filed an 8-K on May 20, 2025, to report on the submission of matters to a vote of its security holders. The filing does not contain specific details about the matters to be voted on or any financial figures.
Why It Matters
This filing indicates that Invivyd, Inc. is convening a meeting or seeking shareholder approval for certain corporate actions, which could impact the company's future direction.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose new financial information or significant corporate events that would immediately impact risk.
Key Players & Entities
- Invivyd, Inc. (company) — Registrant
- Adagio Therapeutics, Inc. (company) — Former Company Name
- May 20, 2025 (date) — Date of Report
FAQ
What specific matters are being submitted for a vote of Invivyd, Inc.'s security holders?
The filing does not specify the exact matters to be voted on, only that they are being submitted for a vote.
When was the earliest event reported in this 8-K filing?
The earliest event reported is May 20, 2025.
What is Invivyd, Inc.'s principal executive office address?
Invivyd, Inc.'s principal executive offices are located at 1601 Trapelo Road, Suite 178, Waltham, MA 02451.
What was Invivyd, Inc.'s former company name?
Invivyd, Inc.'s former company name was Adagio Therapeutics, Inc.
What is the SEC file number for Invivyd, Inc.?
Invivyd, Inc.'s SEC file number is 001-40703.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 20, 2025 regarding Invivyd, Inc. (IVVD).